KRAS and non-small cell lung carcinoma: To further prove the inhibitory effect of LGK974 on other KRAS-mutant NSCLC cells, we tested several KRASG12V mutant NSCLC cells (RERF-LC-AD2, H2444, H441) and KRASG12D mutation cells (SK-LU-1) (Figure S7a,b).